Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.33 USD | +4.76% | +7.46% | +6.80% |
12:42pm | Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 | MT |
May. 14 | Transcript : Daré Bioscience, Inc., Q1 2024 Earnings Call, May 14, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.80% | 31.68M | |
+26.15% | 49.18B | |
+0.90% | 42.11B | |
+49.90% | 40.37B | |
-5.26% | 28.85B | |
+13.40% | 26.09B | |
-22.30% | 18.71B | |
+8.49% | 13.26B | |
+32.40% | 12.32B | |
+0.45% | 11.99B |
- Stock Market
- Equities
- DARE Stock
- News Daré Bioscience, Inc.
- Transcript : Daré Bioscience, Inc., Q2 2020 Earnings Call, Aug 12, 2020